top of page
All posts
Alzheimer's
ANVISA
Author: Allan Matsui
Author: Jairo Utimi
Author: Claudia Cilento
Author: Nilva Bortoleto
BPF
Cannabidiol
Cancer
Cannabis
Coronavirus
Covid-19
challenges
Epilepsy
pharmaceutical
IFA
pharmaceutical industry
Inovatie
medicines
opportunities
Parkinson
pharmaceuticals
pharmaceutical industry
Author: Camille Rodrigues da Silva
Incremental innovation
Investments
Marketing
News
Incremental innovation
Good Manufacturing Practices
Search
Oct 17, 2024
Anvisa publishes the list of active ingredients of medicines with registration requests under analysis
Sep 12, 2024
We must support Anvisa
Aug 5, 2024
GGBIO task force: solution or palliative?
Jul 11, 2024
Anvisa: 25 years with many stories to tell
Jun 17, 2024
Anvisa's General Management of Medicines releases the 2023 Management Report
May 31, 2024
Real-world studies for drug registration: ANVISA guidelines
Feb 7, 2024
Find out about Anvisa's priorities for the next biennium
Nov 21, 2023
RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.
Oct 26, 2023
WHAT ARE THE STEPS FOR OBTAINING AUTHORIZATION FOR CLINICAL STUDIES IN BRAZIL?
Oct 9, 2023
Important circumstances for the submission of drug registration in Brazil
Sep 29, 2023
What are the topics of interest and ANVISA’s availability for meetings?
Aug 22, 2023
What is the purpose of registration submission guide, based on data from scientific literature?
Apr 7, 2022
ANVISA – Post-pandemic challenges and perspectives.
Dec 22, 2021
Clinical research in Brazil – New horizons, new challenges
Dec 22, 2021
ANVISA has just published the new version of the Cadifa Manual, but what were the main changes?
Feb 9, 2021
Unraveling the Abbreviated Development Path
Feb 9, 2021
Publication of the Public Consultation for the review of RDC 200 - what is new?
Feb 9, 2021
NEW REGULATORY FRAMEWORK OF API
Feb 9, 2021
INCREMENTAL INNOVATION: How to prepare for the changes that will come with the revision of RDC 200
Feb 9, 2021
COVID-19: What facilities is ANVISA providing at this time of crisis?
1
2
E-BOOKS
CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM
SEU TRABALHO
Acesse
bottom of page
